Compounds > taurocholic acid
Page last updated: 2024-08-17

taurocholic acid and amiodarone

taurocholic acid has been researched along with amiodarone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, T; Adachi, H; Asano, N; Fujiwara, K; Iinuma, K; Ito, S; Kondo, Y; Matsuno, S; Nishio, T; Nunoki, K; Okabe, M; Onogawa, T; Seki, M; Shiiba, K; Shimosegawa, T; Suzuki, M; Suzuki, T; Tanemoto, M; Tokui, T; Unno, M1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Barlow, JW; Lim, CF; Raggatt, LE; Stockigt, JR; Topliss, DJ1
Brouwer, KL; Ferslew, BC1

Other Studies

5 other study(ies) available for taurocholic acid and amiodarone

ArticleYear
Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner.
    Endocrinology, 2001, Volume: 142, Issue:5

    Topics: Amino Acid Sequence; Animals; Anion Transport Proteins; Blotting, Northern; Carrier Proteins; Humans; Molecular Sequence Data; Organ Specificity; Rats; Reverse Transcriptase Polymerase Chain Reaction; Thyroid Hormones

2001
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Characterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferases.
    Thyroid : official journal of the American Thyroid Association, 1992,Spring, Volume: 2, Issue:1

    Topics: Amiodarone; Animals; Binding Sites; Binding, Competitive; Cytosol; Diclofenac; Dithiothreitol; Dose-Response Relationship, Drug; Durapatite; Furosemide; Glutathione Transferase; Hydrocortisone; Hydroxyapatites; In Vitro Techniques; Iopanoic Acid; Liver; Macaca fascicularis; Mefenamic Acid; Sulfobromophthalein; Taurocholic Acid; Triiodothyronine

1992
Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates.
    Toxicological sciences : an official journal of the Society of Toxicology, 2014, Volume: 139, Issue:1

    Topics: Amiodarone; Animals; Anions; Azithromycin; Biliary Tract; Cells, Cultured; Chloroquine; Desipramine; Fluorobenzenes; Gentamicins; Hepatocytes; Male; Models, Biological; Phospholipids; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Taurocholic Acid

2014